GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (WBO:TLRY) » Definitions » YoY EBITDA Growth

Tilray Brands (WBO:TLRY) YoY EBITDA Growth : 95.39% (As of Feb. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Tilray Brands YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Tilray Brands's YoY EBITDA Growth for the quarter that ended in Feb. 2024 was 95.39%.

Tilray Brands's EBITDA per Share for the three months ended in Feb. 2024 was €-0.08.


Tilray Brands YoY EBITDA Growth Historical Data

The historical data trend for Tilray Brands's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tilray Brands YoY EBITDA Growth Chart

Tilray Brands Annual Data
Trend Aug14 May15 May16 May17 May18 May19 May20 May21 May22 May23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -131.88 -207.58 -270.44 35.64 -291.74

Tilray Brands Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,197.53 91.79 67.65 79.66 95.39

Tilray Brands YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Tilray Brands's YoY EBITDA Growth for the fiscal year that ended in May. 2023 is calculated as:

YoY EBITDA Growth (A: May. 2023 )
=(EBITDA per Share (A: May. 2023 )-EBITDA per Share (A: May. 2022 ))/ | EBITDA per Share (A: May. 2022 ) |
=(-1.896--0.484)/ | -0.484 |
=-291.74 %

Tilray Brands's YoY EBITDA Growth for the quarter that ended in Feb. 2024 is calculated as:

YoY EBITDA Growth (Q: Feb. 2024 )
=(EBITDA per Share (Q: Feb. 2024 )-EBITDA per Share (Q: Feb. 2023 )) / | EBITDA per Share (Q: Feb. 2023 )) |
=(-0.082--1.778)/ | -1.778 |
=95.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tilray Brands YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Tilray Brands's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Tilray Brands (WBO:TLRY) Business Description

Traded in Other Exchanges
Address
265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol.